DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation. Yang S, Cheng M, Zhang S, Wang H, et al. PLoS One 2025;20:e0321889.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang S, Cheng M, Zhang S, Wang H, et al. DNMT3A facilitates breast cancer progression via regulating ADAMTS8 mediated EGFR-MEK-ERK activation. PLoS One 2025;20:e0321889.
PMID: 40323963